Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Consequently, the race for a potent, non-peptide oral alternative is a central pillar of current pharmaceutical innovation
Oddly, this time, the system didnt ask for any kind of ID or drivers license at all
Thomas DW, Mannon RB, Mannon PJ, Latour A, Oliver JA, Hoffman M, Smithies O, Koller BH, Coffman TM (1998) Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2
Targeting CYP17: established and novel approaches in prostate cancer
US$ 25.52
US$ 29.50
US$ 24.00
